These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 29998573)

  • 21. Concentration Accuracy of Compounded Mitomycin C for Ophthalmic Surgery.
    Kinast RM; Akula KK; Mansberger SL; Barker GT; Gardiner SK; Whitson E; DeBarber AE
    JAMA Ophthalmol; 2016 Feb; 134(2):191-5. PubMed ID: 26661632
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Stability of three commonly compounded extemporaneous enrofloxacin suspensions for oral administration to exotic animals.
    Petritz OA; Guzman DS; Wiebe VJ; Papich MG
    J Am Vet Med Assoc; 2013 Jul; 243(1):85-90. PubMed ID: 23786194
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The efficacy of milbemycin oxime against pre-adult Spirocerca lupi in experimentally infected dogs.
    Kok DJ; Schenker R; Archer NJ; Horak IG; Swart P
    Vet Parasitol; 2011 Apr; 177(1-2):111-8. PubMed ID: 21168275
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparative speed of kill of sarolaner (Simparica) and spinosad plus milbemycin oxime (Trifexis) against induced infestations of Ctenocephalides felis on dogs.
    Six RH; Everett WR; Myers MR; Mahabir SP
    Parasit Vectors; 2016 Feb; 9():93. PubMed ID: 26896448
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Assessment of the combination of spinosad and milbemycin oxime in preventing the development of canine Angiostrongylus vasorum infections.
    Böhm C; Schnyder M; Thamsborg SM; Thompson CM; Trout C; Wolken S; Schnitzler B
    Vet Parasitol; 2014 Jan; 199(3-4):272-7. PubMed ID: 24269160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Stability and uniformity of extemporaneous preparations of voriconazole in two liquid suspension vehicles at two storage temperatures.
    Nguyen KQ; Hawkins MG; Taylor IT; Wiebe VJ; Tell LA
    Am J Vet Res; 2009 Jul; 70(7):908-14. PubMed ID: 19566477
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Prevalence, determinants, and characteristics of extemporaneous compounding in Jordanian pharmacies.
    AlKhatib HS; Jalouqa S; Maraqa N; Ratka A; Elayeh E; Al Muhaissen S
    BMC Health Serv Res; 2019 Nov; 19(1):816. PubMed ID: 31703672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Doxycycline concentration over time after storage in a compounded veterinary preparation.
    Papich MG; Davidson GS; Fortier LA
    J Am Vet Med Assoc; 2013 Jun; 242(12):1674-8. PubMed ID: 23725430
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Stability of an extemporaneously compounded baclofen oral liquid.
    Johnson CE; Hart SM
    Am J Hosp Pharm; 1993 Nov; 50(11):2353-5. PubMed ID: 8266961
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stability of ursodiol in an extemporaneously compounded oral liquid.
    Johnson CE; Nesbitt J
    Am J Health Syst Pharm; 1995 Aug; 52(16):1798-1800. PubMed ID: 8528836
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of milbemycin oxime against Ancylostoma caninum in dogs with naturally acquired infection.
    Wade CG; Mercer SH; Hepler DI; Craig TM
    Am J Vet Res; 1991 Jun; 52(6):951-3. PubMed ID: 1883101
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Efficacy of two anthelmintic treatments, spinosad/milbemycin oxime and ivermectin/praziquantel in dogs with natural Toxocara spp. infection.
    Heredia Cardenas R; Romero Núñez C; Miranda Contreras L
    Vet Parasitol; 2017 Nov; 247():77-79. PubMed ID: 29080769
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Potency and stability of compounded cyclophosphamide: a pilot study.
    Robat C; Budde J
    Vet Comp Oncol; 2017 Sep; 15(3):706-709. PubMed ID: 27028306
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An LC-MS method for determination of milbemycin oxime in dog plasma.
    Xu Q; Li J; Shen Z; Guo S; Wang Y; Li F
    J Chromatogr Sci; 2014 Oct; 52(9):999-1004. PubMed ID: 24072929
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Extemporaneous compounding in veterinary practice: a New Zealand perspective.
    Gargiulo DA; Chemal C; Joda L; Lee YJ; Pilkington M; Haywood A; Garg S
    N Z Vet J; 2013 Nov; 61(6):311-5. PubMed ID: 23544952
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Compounded equine drugs seized from Kentucky pharmacy.
    Kuehn BM
    J Am Vet Med Assoc; 2004 Oct; 225(7):993-4. PubMed ID: 15515973
    [No Abstract]   [Full Text] [Related]  

  • 37. Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension.
    Manchanda A; Laracy M; Savji T; Bogner RH
    Int J Pharm Compd; 2018; 22(1):66-75. PubMed ID: 29385387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinical efficacy of milbemycin oxime in the treatment of nasal mite infection in dogs.
    Gunnarsson LK; Möller LC; Einarsson AM; Zakrisson G; Hagman BG; Christensson DA; Uggla AH; Hedhammar AA
    J Am Anim Hosp Assoc; 1999; 35(1):81-4. PubMed ID: 9934934
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Field evaluation of the efficacy and safety of a combination of spinosad and milbemycin oxime in the treatment and prevention of naturally acquired flea infestations and treatment of intestinal nematode infections in dogs in Europe.
    Hayes B; Schnitzler B; Wiseman S; Snyder DE
    Vet Parasitol; 2015 Jan; 207(1-2):99-106. PubMed ID: 25465736
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Characteristics of commercially manufactured and compounded protamine zinc insulin.
    Scott-Moncrieff JC; Moore GE; Coe J; Lynn RC; Gwin W; Petzold R
    J Am Vet Med Assoc; 2012 Mar; 240(5):600-5. PubMed ID: 22332631
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.